FTC clears sale of Bristol-Myers unit

01/8/2008 | Boston Globe (tiered subscription model), The

The Federal Trade Commission said it has approved the sale of Bristol-Myers Squibb Co.'s medical-imaging unit to private-equity firm Avista Capital Partners for $525 million. The sale, which was announced by Bristol-Myers last month, is part of the company's restructuring efforts to focus on pharmaceuticals.

View Full Article in:

Boston Globe (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY